FE203799

· GlyPharma Therapeutics

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for FE203799, covering 2024-10-24 to 2024-10-26. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Efficacy, PD of FE203799 in Short Bowel Syndrome on Parenteral Support [Phase 1, Phase 2]